Therapeutic Classification: antihypertensives
Pharmacologic Classification: angiotensin II receptor antagonists
Absorption: Olmesartan medoxomil is a prodrug that is converted to olmesartan (the active component); 26% bioavailability of olmesartan.
Distribution: Crosses the placenta.
Protein Binding: 99%.
Half-Life: 13 hr.
Contraindicated in:
Use Cautiously in:
CV: hypotension
F and E: hyperkalemia
GI: sprue-like enteropathy
GU: impaired renal function
Neuro: dizziness
Misc: ANGIOEDEMA
Drug-drug:
Lab Test Considerations: